stocksCOVIDH
COVIDH

iSERA Lifesciences Ltd.

143.90+0.0 (+0.00%)
27 Jul, 12:00 AM

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBoxTMWhat is StyleBox?

Neutral

This stock could not be classified into any of the StyleBoxes and hence a neutral stance.

Detail >
QVM scoreWhat is QVM score?
Score not available. Market cap may be < ₹100 Cr or data unavailable.
Analyst ratingWhat is Analyst rating?
No active sell-side coverage. Recommendations not available.
Technical indicatorsSee all >

61 %

iSERA Lifesciences Ltd. on 1D timeframe is bullish for 14 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance
NIFTY50
NIFTYIT
Add benchmark
Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary
COVIDHNIFTY50NIFTYIT
Start Period01 Mar 202101 Mar 202101 Mar 2021
End Period27 Jul 202627 Jul 202627 Jul 2026
Cumulative Return-33.59%62.56%19.9%
CAGR-7.31%9.43%3.42%
Volatility (ann.)85.83%26.05%35.45%
Max Drawdown -99.77%-16.92%-34.74%
RoMaD -0.07%0.56%0.1%
Sharpe3.521.180.4
Sortino3.741.920.56
Sortino/√22.641.350.4

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

0.0 / 100

iSERA Lifesciences Ltd. is overvalued relative to other stocks in the market

What is Value score?
Momentum score

36.9 / 100

iSERA Lifesciences Ltd. has moderate momentum relative to other stocks in the market

What is Momentum score?
Quality score
Score not available.
QVM score
Score not available.

A comprehensive scorecard to compare iSERA Lifesciences Ltd. on all metrics with other stocks. Access both rank and scores.

Value
Market
(All Stocks in NSE)
Sector
(Information Technology)
Industry Group
(IT - Software)
Industry
(Computers - Software & Consulting)
Size and Listing
Market Cap
121 Cr
Liquidity
Avg daily turnover 1M
0 Cr
Avg daily volume 1M
2,824
Avg daily turnover 3M
0 Cr
Avg daily volume 3M
3,212
Delivery Percentage
100.00%
Volume surge ratio
0.88
Ownership
DII Holding %
0.00%
QoQ change DII holding %
0.00%
FII Holding %
0.00%
QoQ change FII holding %
0.00%
QoQ change Gov holding %
0.00%
Promoter holding %
58.63%
QoQ change Promoter holding %
0.00%
Promoter pledged %
0.00%
Retail Holding %
37.47%
QoQ change Retail holding %
-0.29%

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans
Benjamin Graham's Value
Piotroski F-Score
Dreman contrarian value
Peter Lynch Growth/Value
O'Shaugnessy Value
Templeton Growth/Value
Warren Buffet’s Consistent Compounders
John Neff’s contrarian value
Richard Driehaus Momentum Strategy
O'Shaughnessy Tiny Titans
1
Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

20.0 / 100

iSERA Lifesciences Ltd. passes 1 out of 5 of this checklist's rules
Hits
Misses

Frequently Asked Questions

What is the PB ratio of iSERA Lifesciences Ltd.?
The Price-to-Book (PB) ratio of iSERA Lifesciences Ltd. is -. It compares the stock's market price to its book value per share.
What is the EV/EBITDA of iSERA Lifesciences Ltd.?
The EV/EBITDA of iSERA Lifesciences Ltd. is -. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.
What is the debt-to-equity ratio of iSERA Lifesciences Ltd.?
The debt-to-equity (D/E) ratio of iSERA Lifesciences Ltd. is -. A lower D/E ratio generally indicates a more financially stable company with less leverage.
What is the promoter holding in iSERA Lifesciences Ltd.?
Promoters hold 58.63% of iSERA Lifesciences Ltd. shares as per the latest quarterly shareholding disclosure.
What is the operating profit margin of iSERA Lifesciences Ltd.?
The operating profit margin of iSERA Lifesciences Ltd. is -, reflecting how much profit the company earns from its core operations relative to revenue.
What is the net profit margin of iSERA Lifesciences Ltd.?
The net profit margin of iSERA Lifesciences Ltd. is available in the Income Statement section of the Statements tab.
What is the Sharpely score for iSERA Lifesciences Ltd.?
On Sharpely's proprietary scoring system, iSERA Lifesciences Ltd. has a Quality Score of -/100, Value Score of 0/100 and Price Momentum Score of 35.7/100. , value is low and price momentum is low. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.